Skip to main content
. 2012 Jul;64(4):341–352. doi: 10.1016/j.ihj.2012.06.003

Table 3.

Test parameters of CYP2C19*2 polymorphism.

All studies of CYP219*2 MACE CVS deaths MI ST Major bleeding
Sensitivity % 31 58 34 43 28
Specificity % 72 71 73 73 72
NPV % 92 99 93 98 94
PPV % 10 3 9 4 6

[MACE = Major Adverse Cardiovascular Event, CV = Cardiovascular and MI = Myocardial Infarction, ST = Stent Thrombosis.]